Expertise in
42
conditions

Dr. Peter S. Fail

Advanced Heart Failure and Transplant Cardiology | Interventional Cardiology | Cardiology
225 Dunn St, 
Houma, LA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
42
conditions
225 Dunn St, 
Houma, LA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Peter Fail is an Advanced Heart Failure and Transplant Cardiologist and an Interventional Cardiologist in Houma, Louisiana. Dr. Fail is highly rated in 42 conditions, according to our data. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Fail is currently accepting new patients.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 18 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Advanced Heart Failure and Transplant Cardiology
Interventional Cardiology
Cardiology
Licenses
Internal Medicine in LA
Hospital Affiliations
Thibodaux Regional Medical Center
Terrebonne General Medical Center - Parish
Lady Of The Sea General Hospital
Ochsner St Mary
Ochsner Lafayette General Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Louisiana Healthcare Connections
  • HMO
  • MANAGED MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Cardiovascular Institute
225 Dunn St, Houma, LA 70360
Other Locations
Cardiovascular Institute
1901 Manhattan Blvd, Suite 200, Harvey, LA 70058

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials

Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Enrollment Status: Recruiting
Publish Date: February 27, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Hemodynamic-GUIDEd Management of Heart Failure
Hemodynamic-GUIDEd Management of Heart Failure
Enrollment Status: Completed
Publish Date: August 07, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2025
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve Replacement
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device
Study Phase: Not Applicable
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study (EVAS 2 Confirmatory IDE Study)
Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study (EVAS 2 Confirmatory IDE Study)
Enrollment Status: Active_not_recruiting
Publish Date: March 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
An Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (HFrEF) - The CorCinch-HFrEF Study
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2025
Intervention Type: Device
Study Phase: Not Applicable
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
An Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
An Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
Enrollment Status: Completed
Publish Date: August 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
Non-randomized, Multicenter Expanded Use Evaluation of the LARIAT® Suture Delivery Device (Appendix 16 to Ongoing Investigation)
Non-randomized, Multicenter Expanded Use Evaluation of the LARIAT® Suture Delivery Device (Appendix 16 to Ongoing Investigation)
Enrollment Status: Completed
Publish Date: March 12, 2024
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 06, 2023
Intervention Type: Device
Study Phase: Not Applicable
AltaValve Early Feasibility Study Protocol
AltaValve Early Feasibility Study Protocol
Enrollment Status: Unknown
Publish Date: September 01, 2023
Intervention Type: Device
Study Phase: Not Applicable
Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
Enrollment Status: Active_not_recruiting
Publish Date: August 22, 2023
Intervention Type: Device
Study Phase: Not Applicable
Left Atrial Appendage Ligation With the LARIAT™ Suture Delivery System as Adjunctive Therapy to Pulmonary Vein Isolation for Persistent or Longstanding Persistent Atrial Fibrillation
Left Atrial Appendage Ligation With the LARIAT™ Suture Delivery System as Adjunctive Therapy to Pulmonary Vein Isolation for Persistent or Longstanding Persistent Atrial Fibrillation
Enrollment Status: Unknown
Publish Date: September 05, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Randomized Evaluation of the TriGuard Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
A Randomized Evaluation of the TriGuard Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation
Enrollment Status: Completed
Publish Date: February 18, 2021
Intervention Type: Procedure, Device
Study Phase: Not Applicable
A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension
A Prospective, Randomized, Adaptive, Double-Blind, Sham-Controlled, Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension
Enrollment Status: Terminated
Publish Date: May 13, 2019
Intervention Type: Other, Device
Study Phase: Not Applicable
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Percutaneous Ventricular Restoration in Chronic Heart Failure Due to Ischemic Heart Disease
Enrollment Status: Terminated
Publish Date: June 23, 2017
Intervention Type: Device
Study Phase: Phase 3
View 17 Less Clinical Trials

18 Total Publications

Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial.
Endovascular Ablation of the Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: The REBALANCE-HF Randomized Clinical Trial.
Journal: JAMA cardiology
Published: October 02, 2024
Similar Doctors
Expertise in
42
conditions
Dr. Shane P. Prejean
Advanced Heart Failure and Transplant Cardiology | Cardiology | Interventional Cardiology
Expertise in
42
conditions
Dr. Shane P. Prejean
Advanced Heart Failure and Transplant Cardiology | Cardiology | Interventional Cardiology

Cardiovascular Institute

225 Dunn St, 
Houma, LA 
 (0.1 miles away)
985-876-0300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Shane Prejean is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Houma, Louisiana. Dr. Prejean is highly rated in 42 conditions, according to our data. His top areas of expertise are Pulmonary Edema, Aortic Valve Stenosis, Pediatric Myocarditis, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Prejean is currently accepting new patients.

Expertise in
53
conditions
Dr. Richard P. Abben
Interventional Cardiology | Cardiology | Cardiac Electrophysiology
Expertise in
53
conditions
Dr. Richard P. Abben
Interventional Cardiology | Cardiology | Cardiac Electrophysiology

Cardiovascular Institute

225 Dunn St, 
Houma, LA 
 (0.1 miles away)
985-876-0300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Abben is an Interventional Cardiologist and a Cardiologist in Houma, Louisiana. Dr. Abben is highly rated in 53 conditions, according to our data. His top areas of expertise are Heart Failure, Pulmonary Edema, Heart Failure with Preserved Ejection Fraction (HFpEF), Pacemaker Implantation, and Cardiac Ablation. Dr. Abben is currently accepting new patients.

Expertise in
46
conditions
Dr. Sandeep A. Patel
Interventional Cardiology | Cardiology
Expertise in
46
conditions
Dr. Sandeep A. Patel
Interventional Cardiology | Cardiology

Cardiovascular Institute

1320 Martin Luther King Drive, 
Thibodaux, LA 
 (14.2 miles away)
985-446-2021
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sandeep Patel is an Interventional Cardiologist and a Cardiologist in Thibodaux, Louisiana. Dr. Patel is highly rated in 46 conditions, according to our data. His top areas of expertise are Hypertensive Heart Disease, Pediatric Myocarditis, Familial Hypertension, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG). Dr. Patel is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fail's expertise for a condition
ConditionClose
View All 17 Distinguished Conditions
View All 24 Advanced Conditions
View All 68 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile